Buscar
Mostrando ítems 21-30 de 205
Nanodevices for Facing New Challenges of Medical Treatments: Stimuli-Responsive Drug Delivery Systems
(Medknow Publications and Media Pvt. Ltd., 2021-01)
The administration of therapeutic agents for the treatment of diseases without inclusion in a pharmaceutical formulation has been rarely reported in the current literature. In this condition, drugs show poor biodistribution ...
Metal Nanoparticles for the Treatment and Diagnosis of Neurodegenerative Brain Diseases
(Bentham Science Publishers Ltd., 2017)
This review focuses on the application of metal nanoparticles in the diagnosis and treatment of Alzheimer's and Parkinson's diseases. Metal nanoparticles present interesting physicochemical properties that can be applied ...
Integration of Fricke gel dosimetry with Ag nanoparticles for experimental dose enhancement determination in theranostics
(Pergamon-Elsevier Science Ltd, 2018-11-22)
The use and implementation of nanoparticles in medicine has grown exponentially in the last twenty years. Their main applications include drug delivery, theranostics, tissue engineering and magneto function. Dosimetry ...
Control of the structure and of the release profile of biological active molecules from materials prepared via sol-gel
(2022-01-01)
The purpose of this paper, which contains both unpublished and published results, is to present and to discuss the efforts made by three generation of women with the objective of correlating the physicochemical and structural ...
Exploiting the natural properties of extracellular vesicles in targeted delivery towards specific cells and tissues
(MDPI, 2020)
Extracellular vesicles (EVs) are important mediators of intercellular communication that participate in many physiological/pathological processes. As such, EVs have unique properties related to their origin, which can be ...
Desenvolvimento de nanopart??culas de ouro (AuNPs) para teran??stica
(IPEN-CNEN/SP, 2022)
Extracellular vesicles as mediators of cancer disease and as nanosystems in theranostic applications
(MDPI, 2021)
Simple Summary Cancer is the second leading cause of death in humans, and in 2020, 9.8 million cancer-related deaths were reported worldwide. In the last 20 years, it has become apparent that small vesicles released by ...
HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors
(Ivyspring Int Publ, 2017-01-01)
Persistent HPV infection alone is not sufficient for cervical cancer development, which requires additional molecular alterations for tumor progression and metastasis ultimately leading to a lethal disease. In this study, ...